Daniel Jacob Hausrath
Hematology/Oncology · Nashville
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · Vanderbilt Health Clinicians, LLC · 127 clinicians in this group
Hospitals listed: Vanderbilt University Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Daniel Jacob Hausrath’s office at (615) 322-3000 to ask if they take your plan before you enroll.
State licence records
1 licence
- Tennessee 65736Medical Doctor · since 2022 · expires 2028-09-30Specialty on the licence: Hematology; Internal Medicine; Medical OncologyLicensedNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
School, training and certification
2 placements
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Education
- University of California San Fransico School of Medicine · MDSan Francisco, CA · 2016Medical school
Residency and fellowship
- Clinical Fellowship, Hematology and Medical OncologyNashville, TN · 2019–2022
- Internship and Residency, Internal MedicineStanford, CA · 2016–2019
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Vanderbilt University Medical CenterNashville, TNAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Vanderbilt Health, which runs 4 hospitalsHome of Vanderbilt-Ingram Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Postoperative hemorrhage or hematoma rate: 3.28 (2.41 to 4.15) · 6,585 cases, Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 1.2 (0.85 to 1.54) · 15,700 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.591, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.703, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,175 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Vanderbilt University Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 9 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3.28 (2.41 to 4.15) · 6,585 cases | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.2 (0.85 to 1.54) · 15,700 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.591 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.703 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,175 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.56 to 1.87) · 4,737 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.13 (0.97 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.72 (117.43 to 174.02) · 459 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 228 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.6 · 135 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.1 · 223 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.2 · 632 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.7 · 466 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 557 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 7,242 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.3 (0.14 to 0.46) · 17,585 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.05 to 0.37) · 18,947 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.16 (1.96 to 4.35) · 7,265 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.33 (0.44 to 2.22) · 4,100 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.05 (6.38 to 11.73) · 4,115 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.74 (3.02 to 6.45) · 4,325 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.48 to 2.84) · 1,745 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 156 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 1.072 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.406 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.337 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.5 · 400 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.1 · 1,055 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -18 · 288 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.6 · 752 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -10.7 · 504 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.4 · 668 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.2 to 6.4) · 1,413 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.4 (9.9 to 13) · 1,413 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.6 · 162 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.9 · 232 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.5 · 215 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 10.9 (8.8 to 13.5) · 4,301 cases | No different | Jan 2022 – Dec 2024 |
What patients said (1,643 patients answered, 22% of those asked)
| Cleanliness | 3 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$14,099
Medicare paid this office $14,099 for 81 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 39 | $3,647 | $94 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 23 | $3,473 | $57 |
| Long return visit (40+ min) | 11 | $2,145 | $102 |
| New patient visit (60+ min) | 14 | $1,762 | $126 |
Who their Medicare patients are
81 Original Medicare patients in 2024. Average age 68 · Under 65 25% · Women 56% · Also on Medicaid 14% · Health risk score 3.16. Sicker patients than 9 in 10 peers; the typical hematology-oncology clinician is at 2.04.
Conditions among them: High blood pressure 75% · Depression 53% · Chronic kidney disease 51% · Diabetes 43% · Coronary heart disease 42% · Heart failure 41% · Atrial fibrillation 35% · Cancer 30% · COPD 28% · Stroke 23%.
The office billed $73,705, Medicare allowed $17,773 and paid $14,099; for 174 services of 9 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 81 | 174 | 68 | 3.16 | $73,705 | $14,099 |
| 2023 | 78 | 161 | 68 | 2.46 | $72,183 | $13,233 |
| 2022 | 44 | 64 | 62 | 2.62 | $21,927 | $5,277 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Long return visit (40+ min) | 22 | $2,765 | $95 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 25 | $2,511 | $97 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $2,237 | $59 |
| New patient visit (60+ min) | 16 | $1,544 | $96 |
2022: 1 service
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $1,398 | $100 |
Drugs they prescribed that Part D paid
$30,220
Pharmacies billed $30,220 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 34) in 2024. Too few prescriptions to compare fairly with other clinicians.
14 generic and 20 brand-name prescriptions · $30,220 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 18 | $27,671 | $1,537 |
Year by year
| 2024 | 34 | 13 | 0% (0) | 59% | $30,220 |
| 2023 | 15 | None | 0% (0) | None | $10,538 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 97.1 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1134581689
- Licence
- TN 65736Tennessee 65736: Licensed
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RH0003X (207RH0003X); Internal medicine (207R00000X)
- Mailing address
- 3841 Green Hills Village Dr, Nashville, TN, 37215
- NPI first listed
- 2016-03-23
- NPI last updated
- 2023-01-12
- NPI record certified
- 2023-01-12
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 300 Pasteur Dr, Stanford, CA, 94305
This office lists an electronic records connection.